Jefferies sets INR 1,260 target for Max Health stock

Published on 10/13/2026 at 14:58 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

June-quarter net income hit INR 3.22 billion. Max Health stock costs INR 861.00 on October 13, 2026 at 3:28 p.m. IST, down 0.57 percent on NSE.

Max Health, INE027H01010, Illustration mit AI erstellt.

Jefferies set a target of INR 1,260.00 for Max Healthcare Institute on October 1, 2026, giving the target 46.34 percent upside from the NSE price of INR 861.00 on October 13, 2026. Business Today reported that the brokerage retained a positive view on Indian hospital stocks while citing regulatory risks around consumables and oncology drugs.

June-quarter earnings provide support

Max Healthcare reported revenue of INR 23.66 billion and net income of INR 3.22 billion for the quarter ended June 30, 2026, according to TickerLandia. The figures give the analyst target a current operating reference, although the share price has moved in the opposite direction during the latest market session.

The company operates hospitals and healthcare services across India, including home healthcare and diagnostic activities. Its latest reported quarter therefore puts the target debate against a business that is still generating billions of rupees in quarterly revenue.

Stock sits near its yearly low

The NSE price of INR 861.00 was 29.54 percent below the 52-week high of INR 1,221.90 and INR 18.95 above the 52-week low of INR 842.05 on October 13, 2026. The stock was down 0.57 percent from the NSE close of October 12, 2026, when it stood at INR 865.95.

Market data also showed a year-to-date decline of 17.62 percent and a one-year decline of 24.69 percent on October 13, 2026. That placement contrasts with Jefferies' INR 1,260.00 target and leaves the current price 31.67 percent below the target after the recent retreat.

Valuation and next scheduled date

Max Health had a market capitalization of INR 838.0 billion and a trailing price-to-earnings ratio of 57.75 on October 13, 2026. The dividend yield was 0.23 percent, while 24 analysts were listed in the latest coverage summary.

The next scheduled quarterly results date was November 20, 2026, according to TickerLandia. Jefferies' October 1 target remains the more immediate valuation reference because it is dated and tied to the current hospital-sector debate.

Comparison with peers

Max Health (NSE, INR): minus 0.57 percent, P/E 57.75, market capitalization INR 838.0 billion.

Apollo Hospitals (NSE, INR): plus 1.23 percent, P/E 54.17, market capitalization INR 1.1 trillion.

Fortis Healthcare (NSE, INR): minus 0.11 percent, P/E 54.50, market capitalization INR 571.1 billion.

Price position remains the key signal

Max Health was last quoted at INR 861.00 on the NSE on October 13, 2026 at 3:28 p.m. IST, down 0.57 percent versus the NSE close of October 12, 2026 at INR 865.95. The further course of trading is shown by the continuously updated market report for Max Health stock.